Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps

Area of Science:

• Biomedical Research
• Preclinical Studies

Background:

• Concerns about biomedical research reliability have emerged, spurred by industry reports highlighting irreproducibility in oncology, endocrinology, and hematology.
• These issues have significant public health implications and have garnered media attention.

Purpose of the Study:

• To assess the scope of irreproducibility in biomedical research.
• To evaluate the effectiveness of current remediation activities focused on transparency and consistency in reporting.

Main Methods:

• Analysis of anecdotal reports from the pharmaceutical industry.
• Review of existing literature on research reproducibility and transparency initiatives.

Main Results:

• Initial reports on irreproducibility are largely anecdotal, lacking quantitative data.
• Remediation efforts focus on improving transparency and consistency in reporting methodologies and results.

Conclusions:

• While transparency initiatives can improve knowledge sharing and best practices, their impact on independent replication and scientific innovation remains a concern.
• Further research is needed to quantitatively assess the extent of irreproducibility and its impact on public health.